PharmaBoardroom

100 Years of Insulin: An Access to Medicines Issue Writ Large

On the 100th anniversary of the development of insulin, regular PharmaBoardroom contributor Brendan Shaw* examines the shocking global disparities in…

Ashraf Mallak – Managing Director GCC, MSD

After almost two decades with MSD, Ashraf Mallak, managing director for the company in the GCC region, dives into the often-overlooked healthcare…

Carsten Hellmann – President & CEO, ALK

Speaking after the recent completion of a three-year strategic transformation plan, ALK President and CEO Carsten Hellmann outlines the progress made…

Turkey: Biosimilars on the Rise

With an already well-established manufacturing industry for pharmaceuticals, Turkey has been aiming to move with global trends and invest in biologics…

Can Turkey Become a True Clinical Trials Hub?

Becoming the clinical trials country leader in the region has been set as a primary goal for Turkey’s pharma industry to achieve global…

GEN: From Niche Distributor to Public Company

Few Turkish companies are experiencing such a transformational moment as GEN. In 2021 alone, the Ankara-based organization made its public debut on…

Global Competitiveness: Where & Why Turkish Pharma Is…

When the Turkish Ministry of Health implemented its strategy to transition from import pharmaceuticals to manufacturing them at home in 2016, the…

Solidarity: How COVID-19 Brought the Turkish R&D Ecosystem…

As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research…

Top 4 Priorities for Turkey’s Minister of Health

Overseeing healthcare for a population of over 80 million, Turkey’s Ministry of Health was put under the spotlight during the COVID-19 pandemic.…

Turkey: Shifting Priorities – Clinical Trials, Biologics,…

There are perhaps no two words that better summarize the last few years in Turkish pharma than localization and pricing. But after years of investment…

Aligning Stakeholder Partnerships in Latin America: Best…

Writing in the November issue of DIA Global Forum, Lawrence Liberti, Mario Alanis, Pravin Chopra, and Silvia Bendiner examine how the COVID-19…

Australia Aiming Targeted Therapies Toward Truly Personalised…

In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association…

Tagged with